Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease - Wikidata - awgldk - TriplyDB

Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease

Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease

http://www.wikidata.org/entity/Q35534824

about

COPD exacerbation: lost in translation Pulmonary function predicting confirmed recovery from lower-respiratory symptoms in World Trade Center-exposed firefighters, 2001 to 2010 Different durations of corticosteroid therapy for exacerbations of chronic obstructive pulmonary disease Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease Self management for patients with chronic obstructive pulmonary disease Inhaled corticosteroids for stable chronic obstructive pulmonary disease Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease Inhaled corticosteroids for stable chronic obstructive pulmonary disease Toll-like receptor 2 expression is decreased on alveolar macrophages in cigarette smokers and COPD patients MMP-9, TIMP-1 and inflammatory cells in sputum from COPD patients during exacerbation Current evidence for the effectiveness of heated and humidified high flow nasal cannula supportive therapy in adult patients with respiratory failure Update on clinical trials in home mechanical ventilation Vitamin D deficiency is associated with the severity of COPD: a systematic review and meta-analysis Natural history of COPD: Focusing on change in FEV1 Chronic obstructive pulmonary disease: respiratory review of 2013 Mechanisms and impact of the frequent exacerbator phenotype in chronic obstructive pulmonary disease Impact of vitamin D on infectious disease Virus-induced exacerbations in asthma and COPD Umeclidinium bromide/vilanterol combination in the treatment of chronic obstructive pulmonary disease: a review Corticosteroids in the treatment of acute exacerbations of chronic obstructive pulmonary disease Respiratory syncytial virus infections enhance cigarette smoke induced COPD in mice A ferret model of COPD-related chronic bronchitis.Optimizing management of chronic obstructive pulmonary disease in the upcoming decade.Can roflumilast, a phosphodiesterase-4 inhibitor, improve clinical outcomes in patients with moderate-to-severe chronic obstructive pulmonary disease? A meta-analysis Pharmacological strategies to reduce exacerbation risk in COPD: a narrative review Pathophysiology of viral-induced exacerbations of COPD The Effects of Air Pollution and Temperature on COPD Respiratory impairment and the aging lung: a novel paradigm for assessing pulmonary function Thioredoxin-1 protects against neutrophilic inflammation and emphysema progression in a mouse model of chronic obstructive pulmonary disease exacerbation Effect of β blockers on mortality after myocardial infarction in adults with COPD: population based cohort study of UK electronic healthcare records Pneumococcal vaccines for preventing pneumonia in chronic obstructive pulmonary disease.Acute exacerbations of chronic obstructive pulmonary disease are associated with decreased CD4+ & CD8+ T cells and increased growth & differentiation factor-15 (GDF-15) in peripheral blood.New clinical insights into chronic obstructive pulmonary disease and their implications for pharmacoeconomic analyses COPD exacerbations. 4: Prevention Exacerbations among chronic bronchitis patients treated with maintenance medications from a US managed care population: an administrative claims data analysis.A score to predict short-term risk of COPD exacerbations (SCOPEX).Moraxella catarrhalis acquisition, airway inflammation and protease-antiprotease balance in chronic obstructive pulmonary disease.Undiagnosed Chronic Obstructive Pulmonary Disease Contributes to the Burden of Health Care Use. Data from the CanCOLD Study.COPD exacerbations in general practice: variability in oral prednisolone courses.Validation of a New Risk Measure for Chronic Obstructive Pulmonary Disease Exacerbation Using Health Insurance Claims Data.

P2860

Q21257182-2EB9E4ED-7CB6-4AAA-BD68-3CAFF09ED981 Q23914158-305C8B4E-653C-4C1F-A357-66F312CA2D35 Q24187361-B4414D0A-B435-4D22-9DFC-6A3E869879C2 Q24193908-1125ABD1-317F-4CD2-855B-3458C0CFDA3F Q24197903-B42EEF90-A28B-47EB-97C0-C995954A59FF Q24202092-5D4C1377-AC65-4062-84FC-E6828958A05A Q24241135-FEE1FCF1-5754-4DF9-BE52-5758EA7E1853 Q24245481-4C725FB0-67C3-4BFC-9C5B-9BECB4D21094 Q24814235-F18999EF-0C9A-443A-B861-656848A58CF7 Q25256354-275771B7-4DA8-4651-B70F-F0AD0B958FAC Q26749320-6409D243-0E21-4036-BC3B-E74F039A1D55 Q26767357-6A3D1B22-2C1D-4AB5-B6E4-39E0DF06DA3B Q26782480-42133F18-6AD4-48E2-AA29-651FC2E6C2E8 Q26801417-8B23EBD0-D296-4908-8C46-00B572912366 Q26864703-E120C465-C4D3-49E6-8029-7652D7B96CF7 Q27000043-BAFC3A5D-10FC-44F7-B987-25CA3BA59627 Q27000724-114CA9B8-F93D-4F63-A4F5-8BA2A4AD1EEA Q27008731-5CA45B4A-2B0D-4DFC-A11A-57057CC4B57A Q27015685-D58DAA77-4D0D-4527-B6AB-3B19C3ACE752 Q27023118-846ED733-F42D-4FCD-B2CC-A9FBC799EF95 Q27317947-334F76BA-DD6F-4DB9-8CE9-9108AE4A8FC2 Q27333635-445E971A-14C8-446E-A9A1-B35F0205EECA Q27693341-DA142A06-7641-47A2-8E68-4A1CB7A4DCE7 Q28070108-51ECB92A-EDF2-4E7D-BB9F-8A8658A51E73 Q28070274-754E0221-1C75-4762-B360-8512719745AF Q28389402-D58B78F4-6EEE-4947-8F0B-AA0CF75ED301 Q28395081-BFBFA040-57BD-4B2B-8C23-4436DCCE8D06 Q28397453-862C222F-35D1-4B65-9672-F8D4662776A1 Q28535004-7B1387DD-4BA0-4485-A12E-07D8BE6C707F Q28660388-9097338B-58E0-4A66-8DE3-C2B1E9CB6608 Q30238816-7211BF8B-80C3-417C-B0C4-EBEE803579DC Q30371420-521F1F5B-E316-48D7-AB38-19E860331522 Q30419928-4CB2CF3B-DAC0-40E0-B178-586DB964C479 Q30480789-EE891424-C51D-452D-AAED-3310009ADA9B Q30617111-C76D74F7-AA42-4B3A-B253-AEBFFE741270 Q30619543-70230CC6-DFC3-422C-8320-C09386D88F64 Q30884939-65486815-662F-4830-9DE8-D76DF75019B8 Q31042243-254CF687-8AF1-4958-AF40-554CA9C16C96 Q31044724-0B38B88A-B480-4550-B6B8-78686D98239E Q31075146-AEF52DED-7E8D-41C1-9C49-B41643A71F95

P2860

Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease

http://www.wikidata.org/entity/Q35534824

description

2002 nî lūn-bûn

@nan

2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Relationship between exacerbat ...... obstructive pulmonary disease

@ast

Relationship between exacerbat ...... obstructive pulmonary disease

@en

type

label

Relationship between exacerbat ...... obstructive pulmonary disease

@ast

Relationship between exacerbat ...... obstructive pulmonary disease

@en

prefLabel

Relationship between exacerbat ...... obstructive pulmonary disease

@ast

Relationship between exacerbat ...... obstructive pulmonary disease

@en

P1433

Q35534824-23D4D619-D3E7-488F-AD84-156A5F21DF2E

P1476

Q35534824-757D91B0-D684-4603-B45D-69BF7A642F05

P2093

Q35534824-1D16C6CF-0B06-4FED-8014-1CB6915E5ABC

Q35534824-BCDFA23C-7D31-453B-A120-B87EF1CBE4AA

Q35534824-CC0E0F0F-E935-4419-8223-44EE863CBAA8

P2860

Q35534824-0DFD51A9-705D-4892-A84B-F4FD2BB0F75E

Q35534824-3C706986-E5CE-479B-9C8E-D28A95E0362D

Q35534824-4D705DB7-2B80-4D5B-9236-5653133115C0

Q35534824-5BAA1A61-F136-4596-AA31-B141A19CAB18

Q35534824-734ECAF4-F64F-40AC-A194-4E6E0C4CA639

Q35534824-8C523ED8-EA02-4EA2-A91F-B267412FF829

Q35534824-A20C23FC-794E-4E8A-9B38-060A8D7EAC3C

Q35534824-A5E1A817-9CA0-4254-85A7-168058D1B936

Q35534824-E48D14D1-D1A3-41AF-A473-5BDE9E5481A3

Q35534824-F462D484-A7A8-4A7C-A385-BB29607E336B

P304

Q35534824-9BA8EB56-7494-4427-A804-160110710514

P31

Q35534824-0C6A7C1F-5A9E-401A-B8E2-2625C4E0338A

P356

Q35534824-1F672C8D-F2A4-4B63-9B1B-F6C408C68284

P407

Q35534824-B3C545A7-61FC-400D-8293-24BF5CE2C776

P433

Q35534824-AA490245-8AC0-4A93-8922-07DD58431074

P478

Q35534824-E7487A7E-2B1A-44C3-8F10-5F97CD459F99

P50

Q35534824-42F5AE9C-2F4C-4A8E-BA1D-27405A36CD4A

P577

Q35534824-7E196D94-A787-40A6-80DB-A9D28B9B8D0C

P5875

Q35534824-83A063EC-CCD9-4FD1-A8FC-C464CA8073C4

P698

Q35534824-CF09159D-D537-4CB2-A6D3-E06C2CE36026

P921

Q35534824-52F00E6F-5D84-4F37-9727-2BA418D3648A

P932

Q35534824-F00687D8-7D82-4ABD-BC84-1B0D866292D7

P356

THORAX.57.10.847

P1433

P1476

Relationship between exacerbat ...... obstructive pulmonary disease

@en

P2093

G C Donaldson

http://www.w3.org/2001/XMLSchema#string

J A Wedzicha

http://www.w3.org/2001/XMLSchema#string

T A R Seemungal

http://www.w3.org/2001/XMLSchema#string

P2860

Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary

Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease.

Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations.

Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations.

Variables associated with changes in spirometry in patients with obstructive lung diseases.

Arterialised earlobe blood gas analysis: an underused technique.

Changing smoking patterns and mortality from chronic obstructive pulmonary disease.

Lower respiratory illnesses promote FEV(1) decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the lung health study.

Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. Copenhagen City Heart Study Group.

P304

847-852

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/THORAX.57.10.847

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

57

http://www.w3.org/2001/XMLSchema#string

P50

P577

2002-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11115474

http://www.w3.org/2001/XMLSchema#string

P698

12324669

http://www.w3.org/2001/XMLSchema#string

P921

chronic obstructive pulmonary disease

P932

1746193

http://www.w3.org/2001/XMLSchema#string